South African variant may evade protection from Pfizer vaccine, study says
The Peninsula
JERUSALEM - The coronavirus variant discovered in South Africa may evade the protection provided by Pfizer/BioNTech's COVID-19 vaccine to some extent, a real-world data study in Israel found, though its prevalence in the country is very low and the research has not been peer reviewed.
The study, released on Saturday, compared almost 400 people who had tested positive for COVID-19, 14 days or more after they received one or two doses of the vaccine, against the same number of unvaccinated patients with the disease. It matched age and gender, among other characteristics.More Related News

Islamic Cultural Center holds lecture on youth empowerment in Islam at Mesaieed International School
Doha, Qatar: With the attendance of 210 students, the Sheikh Abdulla Bin Zaid Al Mahmoud Islamic Cultural Center organised a lecture entitled Youth E...






